Emerald Advisers’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-830
Closed -$389K 295
2021
Q4
$389K Sell
830
-100
-11% -$46.9K 0.01% 202
2021
Q3
$395K Hold
930
0.01% 201
2021
Q2
$334K Hold
930
0.01% 216
2021
Q1
$262K Hold
930
0.01% 225
2020
Q4
$263K Hold
930
0.01% 221
2020
Q3
$256K Hold
930
0.01% 219
2020
Q2
$211K Buy
+930
New +$211K 0.01% 216
2020
Q1
Sell
-2,520
Closed -$379K 323
2019
Q4
$379K Hold
2,520
0.02% 204
2019
Q3
$357K Hold
2,520
0.02% 203
2019
Q2
$315K Hold
2,520
0.01% 215
2019
Q1
$278K Hold
2,520
0.01% 223
2018
Q4
$247K Hold
2,520
0.01% 225
2018
Q3
$311K Hold
2,520
0.01% 230
2018
Q2
$250K Hold
2,520
0.01% 235
2018
Q1
$222K Hold
2,520
0.01% 237
2017
Q4
$249K Hold
2,520
0.01% 228
2017
Q3
$243K Hold
2,520
0.01% 217
2017
Q2
$238K Sell
2,520
-11,973
-83% -$1.13M 0.01% 208
2017
Q1
$1.18M Hold
14,493
0.05% 182
2016
Q4
$1.23M Sell
14,493
-114,020
-89% -$9.67M 0.05% 177
2016
Q3
$9.57M Hold
128,513
0.43% 88
2016
Q2
$9.75M Buy
128,513
+10,743
+9% +$815K 0.47% 76
2016
Q1
$8.16M Buy
117,770
+24,850
+27% +$1.72M 0.4% 84
2015
Q4
$5.6M Hold
92,920
0.26% 118
2015
Q3
$5.03M Hold
92,920
0.26% 121
2015
Q2
$5.4M Hold
92,920
0.26% 120
2015
Q1
$5.2M Buy
92,920
+13,360
+17% +$748K 0.26% 123
2014
Q4
$4.24M Sell
79,560
-46,380
-37% -$2.47M 0.22% 134
2014
Q3
$5.64M Hold
125,940
0.33% 99
2014
Q2
$5.31M Buy
125,940
+250
+0.2% +$10.5K 0.3% 110
2014
Q1
$5.54M Sell
125,690
-22,470
-15% -$990K 0.31% 115
2013
Q4
$7.27M Sell
148,160
-78,730
-35% -$3.86M 0.39% 88
2013
Q3
$9.34M Buy
226,890
+2,800
+1% +$115K 0.53% 67
2013
Q2
$7.87M Buy
+224,090
New +$7.87M 0.48% 71